What does APOTHEEK VELTEM_PHARMA do?

APOTHEEK VELTEM_PHARMA is a pharmacy in Herent. Public Limited, started on 13 December 1985, 1 establishment.

What is the address of APOTHEEK VELTEM_PHARMA?

The registered office of APOTHEEK VELTEM_PHARMA is located at Stationsstraat 37, 3020 Herent.

Is APOTHEEK VELTEM_PHARMA still active?

Yes. According to the CBE (30 October 2026) APOTHEEK VELTEM_PHARMA is active, legal situation “Normale toestand”, started on 13 December 1985.

Is APOTHEEK VELTEM_PHARMA registered on Peppol?

Yes, APOTHEEK VELTEM_PHARMA is registered on the Peppol network with ID 0208:0428228967.

What is the enterprise number of APOTHEEK VELTEM_PHARMA?

The enterprise number of APOTHEEK VELTEM_PHARMA is BE0428228967.

When was APOTHEEK VELTEM_PHARMA founded?

APOTHEEK VELTEM_PHARMA was founded on 13 December 1985.

Who are the directors of APOTHEEK VELTEM_PHARMA?

According to the 2025 annual accounts, the directors of APOTHEEK VELTEM_PHARMA are: Markri-Farma BV.

Is APOTHEEK VELTEM_PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 December 1985; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK VELTEM_PHARMA make in 2025?

APOTHEEK VELTEM_PHARMA posted a profit after taxes of € 167,043 in financial year 2025.

What is the revenue of APOTHEEK VELTEM_PHARMA?

As a small company, APOTHEEK VELTEM_PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 425,653.

How much does an employee at APOTHEEK VELTEM_PHARMA earn?

The average wage cost per full-time employee at APOTHEEK VELTEM_PHARMA was € 71,300 in 2025: staff costs of € 114,139 for 1.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK VELTEM_PHARMA have?

According to the 2025 annual accounts, APOTHEEK VELTEM_PHARMA has 1.6 full-time equivalents (FTE).

Does APOTHEEK VELTEM_PHARMA have a website?

Yes, APOTHEEK VELTEM_PHARMA has a website at veltempharma.be.

APOTHEEK VELTEM_PHARMA (Public Limited) - Herent

Dossier APOTHEEK VELTEM_PHARMA, printed on 30 October 2026 from databakkes.be/en/0428228967/apotheek-veltem-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK VELTEM_PHARMA from Herent, company number BE0428228967, closed financial year 2025 with a result of € 167,043 after tax. For that financial year APOTHEEK VELTEM_PHARMA recorded a gross margin of € 425,653 and equity of € 919,661. Compared with financial year 2024, the result moved from € 209,294 to € 167,043. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 28, 2026.

What it is worth Growing

€ 919,661

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 167,043

▼ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 270,667

▲ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

60 % of the profit went to the shareholders, mostly to MARKRI-FARMA (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.6

▼ 0.1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 114,139

▲ 10% vs 2024

€ 71,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 14,460

▲ € 12,747 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 422,416

▼ 9% vs 2024

€ 60,115 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 113,351

▲ 54% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 25,647

▲ 103% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 393,233 Gross margin 2022: € 393,233 First fiscal year in the series	€ 446,775 Gross margin 2023: € 446,775 ▲ 14% vs 2022 (€ 393,233) Favourable step	€ 468,022 Gross margin 2024: € 468,022 ▲ 5% vs 2023 (€ 446,775) Favourable step	€ 425,653 Gross margin 2025: € 425,653 ▼ 9% vs 2024 (€ 468,022) Unfavourable step	▼ 9%
Profit after taxes	€ 174,012 Profit after taxes 2022: € 174,012 First fiscal year in the series	€ 210,548 Profit after taxes 2023: € 210,548 ▲ 21% vs 2022 (€ 174,012) Favourable step	€ 209,294 Profit after taxes 2024: € 209,294 ▼ 1% vs 2023 (€ 210,548) Unfavourable step	€ 167,043 Profit after taxes 2025: € 167,043 ▼ 20% vs 2024 (€ 209,294) Unfavourable step	▼ 20%
Equity	€ 547,775 Equity 2022: € 547,775 First fiscal year in the series	€ 718,324 Equity 2023: € 718,324 ▲ 31% vs 2022 (€ 547,775) Favourable step	€ 852,618 Equity 2024: € 852,618 ▲ 19% vs 2023 (€ 718,324) Favourable step	€ 919,661 Equity 2025: € 919,661 ▲ 8% vs 2024 (€ 852,618) Favourable step	▲ 8%
Total debts	€ 392,917 Total debts 2022: € 392,917 First fiscal year in the series	€ 363,765 Total debts 2023: € 363,765 ▼ 7% vs 2022 (€ 392,917) Favourable step	€ 627,716 Total debts 2024: € 627,716 ▲ 73% vs 2023 (€ 363,765) Unfavourable step	€ 665,614 Total debts 2025: € 665,614 ▲ 6% vs 2024 (€ 627,716) Unfavourable step	▲ 6%
Cash	€ 165,759 Cash 2022: € 165,759 First fiscal year in the series	€ 248,275 Cash 2023: € 248,275 ▲ 50% vs 2022 (€ 165,759) Favourable step	€ 204,038 Cash 2024: € 204,038 ▼ 18% vs 2023 (€ 248,275) Unfavourable step	€ 270,667 Cash 2025: € 270,667 ▲ 33% vs 2024 (€ 204,038) Favourable step	▲ 33%
Land & buildings	€ 341,188 Land & buildings 2022: € 341,188 First fiscal year in the series	€ 314,559 Land & buildings 2023: € 314,559 ▼ 8% vs 2022 (€ 341,188) Unchanged	€ 700,072 Land & buildings 2024: € 700,072 ▲ 123% vs 2023 (€ 314,559) Unchanged	€ 741,960 Land & buildings 2025: € 741,960 ▲ 6% vs 2024 (€ 700,072) Unchanged	▲ 6%
Retained profit	€ 485,775 Retained profit 2022: € 485,775 First fiscal year in the series	€ 656,324 Retained profit 2023: € 656,324 ▲ 35% vs 2022 (€ 485,775) Favourable step	€ 790,618 Retained profit 2024: € 790,618 ▲ 20% vs 2023 (€ 656,324) Favourable step	€ 857,661 Retained profit 2025: € 857,661 ▲ 8% vs 2024 (€ 790,618) Favourable step	▲ 8%
Dividend	€ 50,000 Dividend 2022: € 50,000 First fiscal year in the series	€ 40,000 Dividend 2023: € 40,000 ▼ 20% vs 2022 (€ 50,000) Unchanged	€ 75,000 Dividend 2024: € 75,000 ▲ 88% vs 2023 (€ 40,000) Unchanged	€ 100,000 Dividend 2025: € 100,000 ▲ 33% vs 2024 (€ 75,000) Unchanged	▲ 33%
Bank debt	€ 240,627 Bank debt 2022: € 240,627 First fiscal year in the series	€ 212,710 Bank debt 2023: € 212,710 ▼ 12% vs 2022 (€ 240,627) Favourable step	€ 462,347 Bank debt 2024: € 462,347 ▲ 117% vs 2023 (€ 212,710) Unfavourable step	€ 422,416 Bank debt 2025: € 422,416 ▼ 9% vs 2024 (€ 462,347) Favourable step	▼ 9%
Balance sheet total	€ 940,692 Balance sheet total 2022: € 940,692 First fiscal year in the series	€ 1,082,089 Balance sheet total 2023: € 1,082,089 ▲ 15% vs 2022 (€ 940,692) Unchanged	€ 1,480,334 Balance sheet total 2024: € 1,480,334 ▲ 37% vs 2023 (€ 1,082,089) Unchanged	€ 1,585,275 Balance sheet total 2025: € 1,585,275 ▲ 7% vs 2024 (€ 1,480,334) Unchanged	▲ 7%
Employees (FTE)	1.6 Employees (FTE) 2022: 1.6 First fiscal year in the series	1.7 Employees (FTE) 2023: 1.7 ▲ 0.1 vs 2022 (1.6) Unchanged	1.7 Employees (FTE) 2024: 1.7 Unchanged (1.7) Unchanged	1.6 Employees (FTE) 2025: 1.6 ▼ 0.1 vs 2024 (1.7) Unchanged	▼ 0.1

Key figures of APOTHEEK VELTEM_PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK VELTEM_PHARMA?

What happened at APOTHEEK VELTEM_PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 28, 2026 New annual accounts for financial year 2025: profit of € 167,043 (▼ 20% vs 2024). Source: NBB ↗
2011 Markri-Farma BV became a director. NBB
Dec 13, 1985 New establishment in Herent. KBO
Dec 13, 1985 Start of the company according to the CBE. KBO

In short

From € 174,012 profit in 2022 to € 167,043 profit in 2025.

Paid € 237,750 in corporate taxes since 2022.

Best year ever: 2023, with € 210,548 profit.

On average € 266,000 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

MARKRI-FARMA 100%

The stake of MARKRI-FARMA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK VELTEM_PHARMA

Behind APOTHEEK VELTEM_PHARMA is Markri-Farma BV. The shares are held by MARKRI-FARMA (100%).

Directors

According to the 2025 annual accounts

Markri-Farma BV

Director · represented by Peeters Marijke

since 2011

Shareholders

MARKRI-FARMA

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Stationsstraat 37

3020 Herent

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

MARKRI-FARMA same network

€ 209,285 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS veltempharma.be

About

Technologies

Alpine.jsApacheBunny CDNFont AwesomeGoogle FontsreCAPTCHA

Hosting & Email

Email provider

Self-hosted

Hosting

AMAZON-02 - Amazon.com, Inc., US

DNS

AWS Route 53

Website info

HTTPS Ja

Languages NL

Features

Webshop Client portal Contact page

Security

✓ HTTPS

✗ SPF

✗ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0428.228.967

VAT number

BE 0428.228.967

Registered office

Stationsstraat 37, 3020 Herent

Names & denominations

APOTHEEK VELTEM_PHARMA

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

13 December 1985

Peppol

Active · Active since 1 Jan 2001

Contact

veltempharma.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK VELTEM_PHARMA

Financials

What happened to APOTHEEK VELTEM_PHARMA?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions